Transient Graves Disease Developing after Surgery for Cushing Disease

American Journal of the Medical Sciences

Volumn 323, Issue 3, 2002, Pages 162-165

  Morita, Hiroyuki ^a   Isaji, Mako ^a   Mune, Tomoatsu ^a   Daido, Hisashi ^a   Isomura, Yukinori ^a   Sarui, Hiroshi ^a   Tanahashi, Tetsuya ^a   Takeda, Noriyuki ^a   Ishizuka, Tatsuo ^a   Yasuda, Keigo ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cushing disease; Graves disease; TSH receptor antibody

Indexed keywords

ADULT; ARTICLE; BLOOD; CASE REPORT; CUSHING SYNDROME; GRAVES DISEASE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION;

ADULT; CUSHING SYNDROME; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0036517473     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200203000-00009     Document Type: Article

References (18)

1. Graham BS, Tucker WS Jr. Opportunistic infections in endogenous Cushing's syndrome. Ann Intern Med 1984;101: 334-8.
2. Takenaka K, Yanase T, Takayanagi R, et al. Cushing's disease preceding sarcoidosis. Intern Med 1995;34:580-3.
3. Uthman I, Senecal JL. Onset of rheumatoid arthritis after surgical treatment of Cushing's disease. J Rheumatol 1995; 22:1964-6.
4. Yakushiji F, Kita M, Hiroi N, et al. Exacerbation of rheumatoid arthritis after removal of adrenal adenoma in Cushing's syndrome. Endocr J 1995;42:219-23.
5. Noguchi Y, Yamai H, Fujisawa K, et al. Systemic lupus erythematosus after pituitary adenomectomy in a patient with Cushing's disease. Clin Endocrinol 1998;48:670-2.
6. Haraguchi K, Hiramatsu K, Onaya T. Transient thyrotoxicosis after unilateral adrenalectomy in two patients with Cushing's syndrome. Enodocrinol Japon 1984;31:577-82.
7. Takasu N, Komiya I, Nagasawa Y, et al. Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma. N Engl J Med 1990;22:1708-12.
8. Yamakita N, Sakata S, Hayashi H, et al. Silent thyroiditis after adrenalectomy in a patient with Cushing's syndrome. Am J Med Sci 1993;305:304-6.
9. Takasu N, Ohara N, Yamada T, et al. Development of autoimmune thyroid dysfunction after bilateral adrenalectomy in a patient with Carney's complex and after removal of ACTH-producing pituitary adenoma in a patient with Cushing's disease. J Endocrinol Invest 1993;16:697-702.
10. Miura K, Aida M, Mihara A, et al. Treatment of Cushing's disease with reserpine and pituitary irradiation. J Clin Endocrinol Metab 1975;41:511-26.
11. Murayama M, Yasuda K, Minamori Y, et al. Long term follow-up of Cushing's disease treated with reserpine and pituitary irradiation. J Clin Endocrinol Metab 1992;75:935-42.
12. McKay LI, Cidlowski JA. Molecular control of immune/ inflammatory responses: interactions between nuclear factor-κB and steroid receptor-signaling pathways. Endocr Rev 1999;20:435-59.
13. McKay LI, Cidlowski JA. CBP (CREB binding protein) integrates NF-κB (nuclear factor-κB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 2000;14:1222-34.
14. Colao A, Pivonello R, Faggiano A, et al. Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease. Clin Endocrinol 2000;53:13-9.
15. Adriaanse R, Brabant G, Endert E, et al. Pulsatile thyrotropin secretion in patients with Cushing's syndrome. Metabolism 1994;43:782-6.
16. Bartalena L, Martino E, Petrini L, et al. The nocturnal serum thyrotropin surge is abolished in patients with ACRH-dependent or ACTH-independent Cushing's syndrome. J Clin Endocrinol Metab 1991;72:1195-9.
17. Codaccioni JL, Orgiazzi J, Blanc P, et al. Lasting remissions in patients treated for Graves' hyperthyroidism with propranolol alone: a pattern of spontaneous evolution for the disease. J Clin Endocrinol Metab 1988;67:656-62.
18. Feldt-Rasmussen U, Schleusener H, Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab 1994;78:98-102.